Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors

Summary

The goals of this study is to determine if nelfinavir can target Epstein-Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV) in patients with certain cancers.

Timeline

Start

2014-07

Primary completion

2016-02

Completion

2016-02

Outcome

Outcome not reported

Stopped (Enrollment): “Very slow accrual; terminated to allow resources to be utilized more effectively on other studies. No data analysis completed, nor any conclusions reached.”

Drugs

Indications